glutamine has been researched along with Phlegmasia Alba Dolens in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dahlbäck, B; He, X; Svensson, PJ; Zöller, B | 1 |
Borchiellini, A; Montaruli, B; Muleo, G; Pannocchia, A; Schinco, P; Tamponi, G; van Mourik, JA; Voorberg, J | 1 |
Alving, BM; Carrington, LR; Gillespie, DL; Griffin, JH | 1 |
Grohmann, J; Koch, HG; Nowak-Göttl, U; Schneppenheim, R; Vielhaber, H | 1 |
Binder, M; Dübbers, A; Kehrel, B; Koch, HG; Nowak-Göttl, U; Veltmann, H; Vielhaber, H | 1 |
Griffin, JH; Petäjä, JM | 1 |
Bathelier, C; Champenois, T; Lucotte, G | 1 |
7 other study(ies) available for glutamine and Phlegmasia Alba Dolens
Article | Year |
---|---|
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
Topics: Arginine; Base Sequence; Drug Resistance; Enzyme Activation; Factor V; Female; Genetic Predisposition to Disease; Glutamine; Heterozygote; Homozygote; Humans; Male; Molecular Sequence Data; Point Mutation; Protein C; Risk Factors; Survival Analysis; Sweden; Thrombophlebitis | 1994 |
Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
Topics: Adult; Arginine; Base Sequence; Factor V; Female; Glutamine; Heterozygote; Homozygote; Humans; Italy; Male; Molecular Sequence Data; Mutation; Myocardial Infarction; Pedigree; Thrombophlebitis; Thrombosis | 1996 |
Resistance to activated protein C: a common inherited cause of venous thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Arginine; Contraceptives, Oral; DNA; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Mutation; Obesity; Pregnancy; Protein C; Protein C Deficiency; Protein S Deficiency; Recurrence; Risk Factors; Thromboembolism; Thrombophlebitis | 1996 |
Arginine506 to glutamin mutation in the factor V gene in infancy and childhood: evidence of fibrinolytic impairment.
Topics: Adolescent; Arginine; Child; Child, Preschool; DNA Mutational Analysis; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Genetic Carrier Screening; Genetic Predisposition to Disease; Glutamine; Homozygote; Humans; Infant; Infant, Newborn; Male; Oligopeptides; Protein C; Thrombin; Thrombophlebitis | 1997 |
Arg506 to Gln mutation in the factor V gene causes poor fibrinolytic response in children after venous occlusion.
Topics: Arginine; Child; Factor V; Fibrinolysis; Glutamine; Humans; Plasminogen Activator Inhibitor 1; Point Mutation; Protein C; Thrombophlebitis; Tissue Plasminogen Activator | 1997 |
Activated protein C resistance: What have we learned now that the dust has settled?
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arginine; Blood Coagulation Disorders; Cerebrovascular Disorders; Drug Resistance; Factor V; Female; Glutamine; Humans; Male; Middle Aged; Myocardial Infarction; Point Mutation; Protein C; Risk Factors; Thrombophlebitis; Thrombosis | 1997 |
ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
Topics: Alleles; Amino Acid Substitution; Arginine; Factor V; France; Gene Frequency; Glutamine; Humans; Point Mutation; Thrombophlebitis | 1998 |